Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2006 2
2009 1
2011 3
2012 4
2013 7
2014 2
2015 4
2016 9
2017 13
2018 14
2019 28
2020 29
2021 21
2022 21
2023 16
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
Tinterri C, Gentile D, Gatzemeier W, Sagona A, Barbieri E, Testori A, Errico V, Bottini A, Marrazzo E, Dani C, Dozin B, Boni L, Bruzzi P, Fernandes B, Franceschini D, Spoto R, Torrisi R, Scorsetti M, Santoro A, Canavese G; SINODAR-ONE Collaborative Group. Tinterri C, et al. Among authors: franceschini d. Ann Surg Oncol. 2022 Sep;29(9):5732-5744. doi: 10.1245/s10434-022-11866-w. Epub 2022 May 12. Ann Surg Oncol. 2022. PMID: 35552930 Clinical Trial.
The Era of Immunotherapy in Small-Cell Lung Cancer: More Shadows Than Light?
Rossi S, Pagliaro A, Michelini A, Navarria P, Clerici E, Franceschini D, Toschi L, Finocchiaro G, Scorsetti M, Santoro A. Rossi S, et al. Among authors: franceschini d. Cancers (Basel). 2023 Dec 8;15(24):5761. doi: 10.3390/cancers15245761. Cancers (Basel). 2023. PMID: 38136306 Free PMC article. Review.
Current radiotherapy techniques in NSCLC: challenges and potential solutions.
Giaj-Levra N, Borghetti P, Bruni A, Ciammella P, Cuccia F, Fozza A, Franceschini D, Scotti V, Vagge S, Alongi F. Giaj-Levra N, et al. Among authors: franceschini d. Expert Rev Anticancer Ther. 2020 May;20(5):387-402. doi: 10.1080/14737140.2020.1760094. Epub 2020 May 13. Expert Rev Anticancer Ther. 2020. PMID: 32321330 Review.
Editorial: Neuroinflammation in the developing brain.
Franceschini D, Zusso M. Franceschini D, et al. Int J Dev Neurosci. 2019 Oct;77:1-2. doi: 10.1016/j.ijdevneu.2019.05.007. Epub 2019 May 29. Int J Dev Neurosci. 2019. PMID: 31152854 No abstract available.
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy.
Mazzola R, Jereczek-Fossa BA, Franceschini D, Tubin S, Filippi AR, Tolia M, Lancia A, Minniti G, Corradini S, Arcangeli S, Scorsetti M, Alongi F. Mazzola R, et al. Among authors: franceschini d. Radiat Oncol. 2020 May 4;15(1):92. doi: 10.1186/s13014-020-01544-0. Radiat Oncol. 2020. PMID: 32366258 Free PMC article. Review.
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360).
Comito T, Loi M, Franzese C, Clerici E, Franceschini D, Badalamenti M, Teriaca MA, Rimassa L, Pedicini V, Poretti D, Solbiati LA, Torzilli G, Ceriani R, Lleo A, Aghemo A, Santoro A, Scorsetti M. Comito T, et al. Among authors: franceschini d. Curr Oncol. 2022 Nov 16;29(11):8802-8813. doi: 10.3390/curroncol29110692. Curr Oncol. 2022. PMID: 36421345 Free PMC article. Clinical Trial.
146 results